Trials / Completed
CompletedNCT00974714
L-arginine Effects on Chronic Hypertension in Pregnancy
Effects of Oral L-arginine on Chronic Hypertension in Pregnancy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- University of Modena and Reggio Emilia · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of oral L-arginine administration on pregnant women at second trimester of gestation with chronic hypertension, respect with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-arginine | Oral L-arginine 2 g twice a day for 14 weeks |
| OTHER | placebo | oral placebo 2 g twice a day for 14 weeks |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2009-06-01
- Completion
- 2009-12-01
- First posted
- 2009-09-10
- Last updated
- 2010-01-20
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00974714. Inclusion in this directory is not an endorsement.